All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

August 9, 2007

Court Dissolves Schering-Plough Consent Decree

Author(s):

Michelle Hoffman

Schering-Plough announced today that a consent decree filed against the company in May, 2002, had been dissolved by the US District Court for the District of New Jersey in Newark.

Kenilworth, NJ (Aug. 2)-Schering-Plough announced today that a consent decree filed against the company in May 2002, had been dissolved by the US District Court for the District of New Jersey in Newark. The consent decree of permanent injunction enjoined the company from manufacturing, packaging, or distributing some 42 products in its Kenilworth and Union, New Jersey, plants and another 13 products in its plants in Manati and Las Piedras, Puerto Rico, because of violations of US Food and Drug Administration’s good manufacturing practices. The company, then under the direction of CEO Richard J. Kogan, was also directed to recall and destroy all lots of Theophylline and Proventil Repetabs in the United States that were still within their labeled expiration periods. Finally, the government levied stiff fines against the company totaling $500 million.

On January 3, 2006, the company announced it had completed all of the 212 significant steps and the 30 validation actions set out by the decree. At the time, the company petitioned the government to dissolve the decree and allow them to reopen the plants.

In a statement issued through a company press release, Fred Hassan, Schering-Plough’s chairman and CEO responded to the dissolution by saying, “This is an important milestone for Schering-Plough as we continue to put issues of the past behind us and make further progress on our Action Agenda. Schering-Plough colleagues have worked hard to establish continuous quality improvement and compliance as part of our culture. In turn, we have been working diligently to earn the trust of our stakeholders. Ensuring quality in our products and systems underpins everything we do.”

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
Advertisement
Skin diseases concept. macro skin of human hand.Medicine and dermatology concept. Details of human skin background. | Image Credit: © daily_creativity - stock.adobe.com
August 9th 2025

Almirall Selects 2nd Dermatology Target in AI Drug Discovery Collaboration with Absci

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 9th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 9th 2025

FDA Moves to Strengthen Drug Supply Chain with PreCheck Program

Susan Haigney
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 9th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
GLP-1 and obesity related newspaper headlines | Image Credit: © zimmywts - stock.adobe.com
August 9th 2025

Lilly’s Oral GLP-1 Candidate Demonstrates 27-Pound Average Weight Loss in Phase III Trial

Patrick Lavery
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 9th 2025

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

Susan Haigney
Related Content
Advertisement
Skin diseases concept. macro skin of human hand.Medicine and dermatology concept. Details of human skin background. | Image Credit: © daily_creativity - stock.adobe.com
August 9th 2025

Almirall Selects 2nd Dermatology Target in AI Drug Discovery Collaboration with Absci

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 9th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 9th 2025

FDA Moves to Strengthen Drug Supply Chain with PreCheck Program

Susan Haigney
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 9th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
GLP-1 and obesity related newspaper headlines | Image Credit: © zimmywts - stock.adobe.com
August 9th 2025

Lilly’s Oral GLP-1 Candidate Demonstrates 27-Pound Average Weight Loss in Phase III Trial

Patrick Lavery
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 9th 2025

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

Susan Haigney
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.